Early diagnosis means little without timely treatment
Early diagnosis only changes outcomes if it is followed by timely treatment.
Newsletters and Deep Dive digital magazine
Early diagnosis only changes outcomes if it is followed by timely treatment.
Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of breast cancer.
A study has shown that, for people living with advanced cancer, a weekly remote check-in with the care team can have a significant impact on outcomes.
In a conversation at ASCO 2026, Dr Fred Saad of the University of Montreal shared some insights from a subgroup analysis of Pluvicto
Editor's Picks
Newsletters and Deep Dive
digital magazine